Joshua Reed | Chief Financial Officer |
Todd Brady | President & Chief Executive Officer |
Marc Goodman | SVB Leerink |
Edwin Zhang | H.C. Wainwright |
Esther Hong | Berenberg |
Prakhar Agrawal | JonesTrading |
Matt Cross | Alliance Global |
Tom Shrader | BTIG |
Yigal Nochomovitz | Citigroup |
Ladies and gentlemen, thank you for standing by, and welcome to the Aldeyra Therapeutics Second Quarter 2021 Financial Results Conference Call. [Operator Instructions] I would now like to hand the conference over to the company's Chief Financial Officer, Joshua Reed. Please go ahead, sir.
Good morning, everyone. With me is Dr.